Pharmacokinetics and pH dependency
By chemical nature, Acidum acetylsalicylicum is a weak acid with $pK_a = 3.5$. The graph of its ionization versus medium $pH$ has a pronounced S-shape. In the acidic environment of the stomach (at $pH$ 1–2), the molecules are predominantly in a lipophilic, non-ionized state, which is why the initial stage of absorption occurs right there.
As the $pH$ shifts toward the alkaline side, the degree of ionization increases sharply: already at $pH$ 4.5, more than 90% of the substance turns into hydrophilic anions. However, the small intestine remains the main site of absorption—its enormous surface area and anatomical features completely nullify the $pH$ factor. In the systemic circulation, the drug undergoes hydrolysis by plasma esterases, resulting in a very short half-life (only 15–20 minutes). The acid is excreted via tubular secretion in the kidneys. If excretion needs to be accelerated, the urine is artificially alkalinized: in an alkaline environment, the substance becomes ionized, and its passive reabsorption is blocked.
Dosing paradox and antiplatelet effect
The key pharmacological challenge when using the drug for thrombosis prevention is to bypass its dual action. Cyclooxygenase (COX) is responsible for the synthesis of two functional antagonists: thromboxane $A_2$ (induces platelet aggregation) and prostacyclin (inhibits aggregation in the endothelium). The goal of therapy is to selectively shut down thromboxane.
Selectivity is achieved due to differences in cell biology:
- Platelets are anucleate elements. Irreversible blockade of COX deprives them of function for their entire lifespan (7–10 days) until new cells arrive from the bone marrow (complete pool renewal takes about 2 days).
- Endothelial cells have a nucleus. They rapidly synthesize new proteins, and prostacyclin production recovers within a few hours.
In addition, about 30% of the ingested dose undergoes presystemic metabolism (deacetylation) during first-pass hepatic metabolism. The concentration in the portal vein is high, which reliably "shuts down" platelets. A lower concentration reaches the systemic circulation, sparing the endothelium. Increasing the dose erodes this gradient, suppressing prostacyclin synthesis and reducing the therapeutic effect.
Safety profile: GI tract and bronchi
The most frequent side effect is an ulcerogenic action. By inhibiting COX, the drug reduces the production of gastroprotective prostaglandins $E_2$ and $I_2$. As a result, mucus and bicarbonate secretion drops, while hydrochloric acid production increases. This leads to erosions and gastrointestinal bleeding even at low doses.
To protect the GI tract, the following are used:
- Enteric-coated formulations (passing through the stomach in transit).
- Combinations with antacids (e.g., magnesium hydroxide, which neutralizes acid).
The second formidable effect is "aspirin-induced asthma." Due to COX blockade, arachidonic acid metabolism switches entirely to the lipoxygenase pathway. The result is massive hyperproduction of leukotrienes, provoking severe bronchospasm.
Contraindications
In addition to ulcerative lesions and bronchial asthma, the drug has a number of strict limitations:
- Age under 5 years: extremely high risk of Reye's syndrome (progressive encephalopathy with cerebral edema, potentially fatal).
- Genetic defects: glucose-6-phosphate dehydrogenase deficiency is fraught with erythrocyte hemolysis due to plasma $pH$ shifts.
- Obstetrics: the third trimester of pregnancy and lactation.
- Organ pathologies: renal dysfunction and risk of uncontrolled bleeding.
The antiplatelet rule: "Platelets are forgetful, but the endothelium is resilient." Anucleate platelets permanently lose blocked COX (for 7–10 days), while nucleated endothelial cells synthesize a new batch of the enzyme within just a few hours.
Class and exam questions
Why are low doses (50–160 mg) used for myocardial infarction prevention?
Low doses, due to presystemic metabolism in the liver, create a high concentration only in the portal vein, blocking platelets. In the systemic circulation, the concentration drops, allowing vascular endothelium to continue synthesizing the beneficial antiplatelet agent, prostacyclin.
How quickly does the effect of taking a tablet occur?
Conventional water-soluble forms work within 20–30 minutes. Enteric-coated tablets work with a delay; in acute situations (e.g., unstable angina), they must be chewed for immediate absorption.
Why does the drug cause bronchospasm?
By blocking the cyclooxygenase pathway, the drug directs the entire pool of arachidonic acid along the alternative lipoxygenase pathway. This leads to excessive synthesis of leukotrienes, which are potent bronchoconstrictors.
What else to study on this topic
- Mathematical calculation of weak acid ionization degree using the Henderson–Hasselbalch equation
- Comparison of the pharmacokinetics of ASA and ascorbic acid in the acidic environment of the stomach
- Mechanism of Reye's syndrome development in children at the biochemical level
- The role of plasma esterases in the systemic metabolism of esters
- Anatomical and physiological advantages of the small intestine as the primary site of absorption
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Acetylsalicylic acid" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.